Gratus Capital’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	$12.4M	Sell	760,289 -9,844	-1%	-$160K	0.49%	59
2024 Q1	$10.9M	Buy	770,133 +1,845	+0.2%	+$26K	0.5%	63
2023 Q4	$8.02M	Buy	768,288 +4,923	+0.6%	+$51.4K	0.45%	70
2023 Q3	$7.79M	Buy	+763,365	New	+$7.79M	0.53%	61